Health Condition 1: B359- Dermatophytosis, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. All the patients diagnosed with recalcitrant dermatophytosis operational definition of Recalcitrant dermatophytosis refers to relapse, recurrences, reinfection, persistence or chronic infections, and possibly microbiological resistance. 2. Both male and female with established recalcitrant dermatophytosis. 3. Age 18- 60 years.
Exclusion criteria
Exclusion criteria: 1.Patient diagnosed with other autoimmune dermatological disease like psoriasis. 2. Patient with cutaneous adverse drug reactions. 3. Patient with secondary infected tinea infection
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To analyse the treatment response to antifungals drugs in patients diagnosed with recalcitrant dermatophytosis patients.Timepoint: At baseline and four weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To assess the prescribing pattern of anti-fungal agents and adherence to available treatment guidelines. 2. To evaluate the adverse drug reactions, patient’s adherence to treatment and cost of therapy associated with recalcitrant dermatophytosis medication. 3. To assess the effect of antifungal therapy on the quality of life of patients. 4. Subgroup analysis – Comparison of treatment response in patients receiving different antifungal agents will be done, if feasible.Timepoint: At baseline and four weeks | — |
Countries
India
Contacts
AIIMS Rishikesh